Personalized Treatment of Urogenital Cancers Depends on the Microbiome
Status:
Recruiting
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial where patients undergoing surgical treatment for
urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics
OR surgical treatment + placebo.